AbbVie

ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.712%

12M weight contribution

-0.104 pp

3M weight contribution

-0.100 pp

12M price return

+18.9%

Share of matched S&P 500 members

Monthly observations through Dec 2024

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Dec 2024	$314.0bn	0.712%	-0.104 pp	+18.9%	No
Nov 2024	$323.3bn	0.713%	-0.070 pp	+33.2%	No
Oct 2024	$360.1bn	0.846%	-0.001 pp	+49.7%	Yes
Sep 2024	$348.8bn	0.812%	-0.067 pp	+37.6%	Yes
Aug 2024	$346.8bn	0.838%	+0.011 pp	+38.7%	Yes
Jul 2024	$327.3bn	0.587%	+0.011 pp	+28.7%	No
Jun 2024	$302.9bn	0.568%	+0.018 pp	+32.5%	No
May 2024	$284.7bn	0.544%	-0.057 pp	+21.6%	No
Apr 2024	$287.3bn	0.832%	-0.071 pp	+12.0%	No
Mar 2024	$321.7bn	0.892%	-0.070 pp	+18.9%	Yes
Feb 2024	$311.0bn	0.891%	-0.066 pp	+19.0%	Yes
Jan 2024	$290.3bn	0.863%	-0.031 pp	+15.8%	Yes
Dec 2023	$273.6bn	0.816%	-0.215 pp	-0.2%	Yes
Nov 2023	$251.4bn	0.784%	-0.184 pp	-8.1%	Yes
Oct 2023	$249.2bn	0.847%	-0.071 pp	+0.3%	Yes
Sep 2023	$263.1bn	0.879%	-0.054 pp	+15.6%	Yes
Aug 2023	$259.4bn	0.827%	-0.024 pp	+13.7%	Yes
Jul 2023	$263.9bn	0.575%	-0.296 pp	+8.5%	No
Jun 2023	$237.7bn	0.550%	-0.503 pp	-8.6%	No
May 2023	$243.4bn	0.601%	-0.337 pp	-2.8%	No
Apr 2023	$267.4bn	0.903%	-0.036 pp	+6.9%	No
Mar 2023	$282.0bn	0.962%	-0.003 pp	+2.1%	Yes
Feb 2023	$272.3bn	0.957%	+0.051 pp	+8.1%	Yes
Jan 2023	$261.3bn	0.894%	+0.080 pp	+12.0%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.